1-3 of 3
Andrew D Norden, MD MPH, MBA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma

Elizabeth B Lamont, MD MS, MMSc, Andrew J. Yee, MD, Stuart L. Goldberg, MD, Andrew D Norden, MD MPH, MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2193.
https://doi.org/10.1182/blood-2019-125407
Published: 2019
Journal Articles

Multiple Myeloma Staging in Real World Clinical Practice Is Suboptimal: Absence of Beta-2-Microglobulin and Serum Lactase Dehydrogenase Testing Are Limiting Factors

Noa Biran, MD, Sukhmani Gill, MD, Andrew D Norden, MD MPH MBA, David H. Vesole, MD PhD, Wallace G Stephen, MD, Kenneth D Nahum, DO, David S Siegel, MD PhD, Stuart L. Goldberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5587.
https://doi.org/10.1182/blood-2018-99-119559
Published: 2018
Journal Articles

FISH Abnormalities (including R-ISS defining and IgH mutations) Are Similar across Race and Ethnicity Among Patients with Multiple Myeloma (except higher rates of t(4:14) in Minorities and 1q Amplifications in Asian/Indians)

Noa Biran, MD, Camille Johnson, MD, Andrew D Norden, MD MPH MBA, Roger Kumar, BS MS, David H. Vesole, MD PhD, Seth H. Berk, MD, Denis B. Fitzgerald, MD, David S Siegel, MD PhD, Stuart L. Goldberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5608.
https://doi.org/10.1182/blood-2018-99-119744
Published: 2018